Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes

Table 4 A logistic regression model for END after propensity score matching^a in patients with diabetes mellitus admitted within 72 h of acute ischemic stroke

	Odds ratio (95% confidence interval)	P
Age	1.01 (0.99–1.03)	0.397
Male sex	1.22 (0.80–1.87)	0.352
Hypertension	1.01 (0.584–1.74)	0.982
Initial NIHSS	1.01 (0.98–1.05)	0.434
TOAST		0.098
Cardioembolism	Reference
Atherosclerosis	1.24 (0.71–2.16)	0.445
Small artery disease	2.01 (1.00–4.02)	0.049
Others	0.95 (0.51–1.75)	0.858
Positive urine proteins	1.40 (0.90–2.17)	0.140
Fibrinogen per 300 mg/dl		0.044
0–300 mg/dL	Reference
300–600 mg/dL	1.62 (1.04–2.53)	0.034
> 600 mg/dL	2.60 (1.02–6.51)	0.046

END early neurological deterioration, NIHSS National Institutes of Health Stroke Scale, TOAST trial of Org 10,172 in acute stroke treatment
^a Age, sex, initial NIHSS and TOAST were adjusted

ISSN: 1471-2377